The 4 Stages of B12 Deficiency Explained
Vitamin B12 deficiency can develop gradually. Some people notice tiredness or tingling before they have anaemia, while others have few symptoms at first. The “four stages” model is sometimes used to explain how B12 depletion can affect blood markers and cell function over time. It is a teaching model, not an official NHS diagnostic staging system, and not everyone follows the same sequence.
This guide explains the four-stage model, what the tests can show and when to seek advice. It forms part of our complete guide to vitamin B12 deficiency and complements our article on B12 deficiency symptoms in women.
The four-stage model is a simplified way to describe possible biological changes. NICE does not diagnose or grade B12 deficiency using four stages. Diagnosis is based on symptoms, risk factors, blood test results and clinical assessment.
Stage 1 – B12 stores and blood levels begin to fall
Vitamin B12 stores may gradually become depleted when intake is too low or the body cannot absorb or use the vitamin properly. At this early point, a person may have no obvious symptoms. A blood result may also need to be interpreted alongside the person’s diet, medicines, medical history and symptoms.
Possible risk factors include a diet low in animal-source or fortified foods, autoimmune gastritis, coeliac disease, some stomach or bowel operations, and certain medicines such as metformin or proton pump inhibitors. Recreational nitrous oxide use can also inactivate B12 and needs specific assessment.
Stage 2 – Less B12 is available to cells
As depletion progresses, the amount of biologically active B12 available to cells may fall. Active B12 is also called holotranscobalamin (holoTC). It is the form carried into cells, whereas a total B12 blood test measures both active and inactive forms circulating in the blood.
Some people may develop symptoms during this period, including unexplained tiredness, difficulty concentrating, a sore tongue or pins and needles. These symptoms are not unique to B12 deficiency, so they should not be used on their own to diagnose it.
Stage 3 – Functional changes may appear
B12 is needed for normal metabolic processes. When there is not enough available B12, substances such as methylmalonic acid (MMA) and homocysteine can build up. A raised MMA can support a diagnosis when an initial B12 result is indeterminate, but the result must be interpreted using the laboratory’s reference range and the person’s clinical context.
Neurological symptoms can include tingling or numbness in the hands and feet, balance or walking difficulties, memory or concentration problems and changes in mood. These symptoms deserve medical assessment. Importantly, neurological problems can occur even when a person does not have anaemia or a raised mean cell volume (MCV).
Stage 4 – Anaemia may develop
If deficiency is prolonged, it can affect red blood cell production. B12 deficiency may cause megaloblastic anaemia, in which red blood cells are larger than usual. A full blood count may show a raised MCV and low haemoglobin.
Possible symptoms include marked tiredness, weakness, pale skin, breathlessness or a racing heartbeat. However, anaemia is not inevitable and its absence does not rule out B12 deficiency. Do not wait for anaemia to develop before asking for advice if you have concerning symptoms or risk factors.
Which blood tests are used?
NICE guideline NG239 recommends using either total B12 (serum cobalamin) or active B12 (serum holotranscobalamin) as the initial test for most adults with suspected deficiency. Active B12 is recommended as the initial test during pregnancy. The choice of test and interpretation should be made by the clinician in the person’s circumstances.
- Total B12: measures the total amount of B12 circulating in the blood.
- Active B12 (holoTC): measures the portion carried on transcobalamin and available for cells to take up.
- MMA: may be considered when symptoms or signs are present and the initial total or active B12 result is indeterminate.
- Full blood count: can identify anaemia and changes in red blood cell size, but a normal blood count does not exclude deficiency.
NICE gives guide thresholds for total and active B12, but local laboratory ranges and clinical circumstances matter. For example, NICE describes total B12 below 180 ng/L as indicating confirmed deficiency, 180–350 ng/L as indeterminate, and above 350 ng/L as making deficiency less likely. For an indeterminate result with symptoms, a clinician may consider an MMA test. Read the full NICE recommendations for vitamin B12 deficiency.
Symptoms and risk factors to discuss with a clinician
Symptoms vary and can overlap with many other conditions. Tell your GP or healthcare professional if you have persistent unexplained fatigue, brain fog, pins and needles, numbness, balance problems, a sore tongue, visual changes or memory difficulties. Mention any restrictive diet, digestive condition, previous gastrointestinal surgery, relevant medicines or nitrous oxide use.
If you have new or worsening numbness, weakness, difficulty walking, balance problems or changes in vision, seek prompt medical advice. Suspected B12 deficiency with neurological symptoms needs timely assessment. Do not start supplements or injections as a substitute for getting unexplained symptoms checked. If possible, blood samples for diagnosis should be taken before starting B12 replacement, because supplements can affect test results; urgent treatment should not be delayed when a clinician considers it necessary.
Why early assessment matters
Recognising possible deficiency before complications develop gives a clinician the opportunity to investigate the cause and recommend appropriate replacement. Treatment depends on why B12 is low. Some people need tablets, while others need injections, and some causes require long-term or lifelong replacement. Symptoms may improve at different rates, and nerve-related symptoms can take longer to recover.
If you need further investigation, a full blood count test can provide information about red blood cells and anaemia. For advice about available pharmacy services, contact Southdowns Pharmacy Group or use the appointment page. A pharmacist can explain the services available and when GP assessment is needed.
A normal haemoglobin or MCV result does not, by itself, rule out B12 deficiency. Equally, symptoms alone cannot confirm it. The right next step is an assessment that considers symptoms, risk factors and appropriate tests.
Frequently asked questions
Are the four stages of B12 deficiency an official diagnosis?
No. The four-stage model is an explanatory framework. NICE guidance does not use these stages to diagnose or grade deficiency.
Can I have B12 deficiency without anaemia?
Yes. NICE advises not to rule out B12 deficiency just because anaemia or macrocytosis is absent.
Can a B12 blood test be borderline?
Yes. An initial total or active B12 result can be indeterminate. If symptoms or signs are present, a clinician may consider further testing such as serum MMA.
What is the difference between total B12 and active B12?
Total B12 measures active and inactive B12 in the blood. Active B12 (holoTC) measures the fraction carried to cells for use.
Does everyone with B12 deficiency need injections?
No. Treatment depends on the cause, symptoms and ability to absorb B12. A healthcare professional can advise whether tablets or injections are appropriate.
This article is for general information and is not a diagnosis or a substitute for medical advice. If you have neurological symptoms, worsening symptoms or concerns about B12 deficiency, contact your GP or another appropriate healthcare professional.
Southdowns Pharmacy Group
Part of the GPhC-registered pharmacy team at Southdowns Pharmacy, providing evidence-based health guidance across our Hampshire branches.
Africa
Caribbean
Australasia & Pacific
Thailand
India
Cape Verde
Kenya